Influenza pandemics occur unpredictably when zoonotic influenza viruses with novel antigenicity acquire the ability to transmit amongst humans 1 . Host range breaches are limited by incompatibilities between avian virus components and the human host. Barriers include receptor preference, virion stability and poor activity of the avian virus RNA-dependent RNA polymerase in human cells 2 . Mutants of the heterotrimeric viral polymerase components, particularly PB2 protein, are selected during mammalian adaptation, but their mode of action is unknown 3-6 . We show that a species-specific difference in host protein ANP32A accounts for the suboptimal function of avian virus polymerase in mammalian cells. Avian ANP32A possesses an additional 33 amino acids between the leucine-rich repeats and carboxy-terminal low-complexity acidic region domains. In mammalian cells, avian ANP32A rescued the suboptimal function of avian virus polymerase to levels similar to mammalian-adapted polymerase. Deletion of the avian-specific sequence from chicken ANP32A abrogated this activity, whereas its insertion into human ANP32A, or closely related ANP32B, supported avian virus polymerase function. Substitutions, such as PB2(E627K), were rapidly selected upon infection of humans with avian H5N1 or H7N9 influenza viruses, adapting the viral polymerase for the shorter mammalian ANP32A. Thus ANP32A represents an essential host partner co-opted to support influenza virus replication and is a candidate host target for novel antivirals.
in a positive avian host factor that was either lacking or different in mammals 10 . To identify this factor, we took advantage of a chicken genome radiation hybrid panel based on the Wg3H hamster cell line and harbouring different fragments of chicken chromosomes 17 . Each radiation hybrid clone was screened for the ability to support activity of a H5N1 avian influenza virus polymerase (A/turkey/England/50-92/91 virus, hereafter called 50-92) compared with its human-adapted isoform bearing PB2(E627K). Four out of 53 clones supported activity of the avian virus polymerase (Fig. 1a ). Owing to instability of the chicken chromosome content, one positive clone lost this phenotype by passage 12. To identify chicken genes expressed in the positive radiation hybrid clones but not in negatives, total RNA was analysed using an Affymetrix chicken gene array. The four early passage positive clones had 35 chicken genes in common ( Fig. 1b ). After P12, the remaining positive hybrids shared only 12 genes in common, all present on a region of chicken chromosome 10 ( Fig. 1c and Extended Data Table 1 ). Genetic instability of the clones is revealed by principal component analysis (PCA) mapping analysis, as is variation between negative clones (Extended Data Fig. 1) .
We targeted candidate genes within this region and co-expressed each individually in human 293T cells with reconstituted H5N1 50-92 influenza virus polymerase. Expression of a single chicken gene, chANP32A (chicken acidic (leucine-rich) nuclear phosphoprotein 32 family, member A), rescued avian virus polymerase activity to levels similar to human-adapted PB2 627K viral polymerase (Fig. 1d ). All positive hybrid clones expressed chANP32A (Extended Data Fig. 2 ). Knockdown of chANP32A abrogated the ability of positive radiation hybrid clone 476 to support avian virus polymerase, suggesting that this single chicken gene was responsible for the phenotype (Extended Data Fig. 3 ). Chicken homologues of DDX17 and members of the importin alpha family previously implicated in host range restriction of influenza virus polymerase did not rescue avian virus polymerase activity in human cells ( Fig. 1d) 18, 19 .
ANP32A is a member of a family of nuclear proteins implicated in multiple cellular pathways, including transcriptional regulation by chromatin remodelling, messenger RNA export and cell death 20 . ANP32 proteins share conserved amino-terminal domains, comprised of leucine rich repeats (LRR) and C-terminal low complexity acidic regions (LCAR) comprised of 60-75% glutamic or aspartic acid ( Fig. 4a and Extended Data Fig. 8 ). We expressed cloned human homologue (huANP32A) as well as human and chicken genes for the related family member ANP32B. Expression of chANP32A, but not huANP32A, in human cells rescued activity of several different avian influenza polymerases including those from low (H1N1 A/duck/Bavaria/79 (Bav), H9N2 A/UDL/2008 (UDL)), and high (H5N1 (A/turkey/ Turkey/05/2005 (Ty05) and A/turkey/England/50-92/91 (50-92)) pathogenicity avian viruses, and a human H3N2 virus (A/Victoria/3/75 (Vic)) when PB2 bore 627E (Extended Data Fig. 4 ). Expression of 1 0 2 | n a T u r E | V O L 5 2 9 | 7 j a n u a r y 2 0 1 6
Letter reSeArCH chANP32A, but not huANP32A, chANP32B or huANP32B, increased levels of all three species of minigenome RNA produced by reconstituted avian viral polymerase in human cells ( Fig. 2a-c) . Increase in levels of viral genomic RNA (vRNA) and complementary antigenomic RNA (cRNA) in the polymerase assay indicates that RNA replication, and not only mRNA transcription or stability, was enhanced by the expression of the chicken host factor in mammalian cells. Expression of chANP32A in human cells did not affect levels or nuclear accumulation of PB2, suggesting that its ability to support polymerase activity in the cell nucleus is not mediated by enhanced nuclear trafficking (Extended Data Fig. 5 ).
Additionally, expression of chANP32A enhanced avian virus replication in human cells. Levels of all three influenza RNA species derived from avian virus segment 1 were increased by expressed chANP32A but not by huANP32A ( Fig. 2d-f ). Moreover, the yield of infectious avian-like influenza virus was enhanced whether chANP32A was expressed in human cells at 33 °C ( Fig. 2g ) or 37 °C (Extended Data Fig. 4c ). In contrast, chANP32A did not enhance yields of an isogenic PB2 627K recombinant virus, and overexpression of huANP32A reduced its titre ( Fig. 2g and Extended Data Fig. 4c ).
We confirmed a role for ANP32A in supporting virus replication in avian cells. In chicken cells (DF-1, immortalized chicken fibroblasts), Wg3h  11  27  45  50  78  81  82  95  140  141  161  162  175  182  190  197  207  243  274  305  307  318  327  331  333  350  364  365  373  375  377  386  397  476  482  511  524  531  536  541  546  557  566  567  576  588  600  608  611  613  628  635  639   Wg3h P12  327 P12  365 P12  377 P12  386 P12  476 Letter reSeArCH short hairpin RNA ( Fig. 3a and Extended Data Fig. 6 ) and short interfering RNA (Fig. 3b ) targeting chANP32A decreased activity of avian virus polymerase (PB2 627E). Knockdown of ANP32A in DF-1 cells also decreased the yield of infectious avian-like influenza virus ( Fig. 3c ). We next investigated whether the human homologues of ANP32A or B support activity of influenza polymerase in human cells. Human ANP32A and B were previously listed in the human influenza A virus interactome 21 , and depletion of huANP32A and/or huANP32B from human cells decreased polymerase activity and replication of human influenza virus 22, 23 . We used sh or siRNA to target huANP32A and B in human cells. Human-adapted viral polymerase (50-92 PB2 627K) activity was reduced when levels of either ANP32A or B were decreased, and further reduced in cells from which both proteins were depleted, suggesting a dependence on both family members ( Fig. 3d and Extended Data Fig. 7 ). Yields of influenza virus A/England/691/2010, a seasonal H3N2 human virus, were decreased in cells depleted of ANP32A and/or ANP32B (Fig. 3e ). We note with interest that both depletion and overexpression of human ANP32A or B were deleterious for polymerase activity and virus yields in human cells (Fig. 2 ), which suggests that influenza virus relies on balanced expression of ANP32 proteins.
Sequence alignment of avian and mammalian ANP32A revealed that avian (except ratite) ANP32A harbours an additional 33 amino Letter reSeArCH acids (176-208), derived partly by a repeat of amino acids 149-175, expressed from an additional exon absent from mammals and ostrich (Extended Data Fig. 8 ). Avian ANP32B does not contain the additional sequence (Extended Data Fig. 8 ). We cloned and Flag-tagged ANP32A cDNA from chicken, turkey, duck, and zebra finch, all of which encode homologues with the additional sequence, and also from ostrich, human, mouse, and pig, all of which were mammalian-like in length ( Fig. 4a, b, d) . The four longer avian proteins increased avian, but not human-adapted, influenza virus polymerase activity in human cells ( Fig. 4c and Extended Data Fig. 9 ). In contrast, the ostrich protein, or any of the mammalian homologues, did not rescue avian virus polymerase activity. Interestingly, replication of avian influenza viruses in ostrich and other ratites selects for mammalian-adapted PB2 mutants 24 .
Deletion of amino acids 176-208 from chANP32A abrogated its ability to support avian virus polymerase. Conversely, insertion of the additional avian-specific 33 amino acids bestowed upon either huANP32A or huANP32B the ability to support avian virus polymerase ( Fig. 4c, d) .
In summary, we conducted a novel screen of chicken genome radiation hybrid cells and identified a single chicken gene, ANP32A, that supports avian influenza virus polymerase activity in human cells. We suggest that avian influenza virus has co-evolved with its natural hosts, wild birds, to co-opt avian ANP32A as a host factor that supports its polymerase activity in the nucleus. The avian influenza polymerase cannot efficiently utilize shorter ANP32 proteins, such as ANP32B or mammalian ANP32A homologues, for this activity. Acquisition of host-adapting mutations, such as PB2(E627K), enables polymerase activity to be supported by the shorter ANP32 proteins typical of mammalian hosts. The underlying mechanism of avian influenza polymerase restriction in human cells has evaded researchers for decades. Others have previously demonstrated a role for PB2 residue 627 in its interaction with NP 12, 25 , and viral RNA promoter sequences 26, 27 that may influence recognition of incoming vRNPS by RIG-I 28 . The nature of residue 627 has also been linked with a PB2 dependency on specific importin family members 19, 29 . How these observations are linked with the species difference in host factor ANP32A we describe here remains to be elucidated.
Substitutions in PB2 are rapidly selected after avian influenza viruses enter mammalian hosts and PB2 adaptation is essential to support the pandemic potential of emerging avian influenza viruses. This stringent requirement for the virus to optimize replication efficiency in the human host suggests that disrupting the interaction of the virus with ANP32A may be a novel means for virus control.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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Rico/8/1934) 30 , UDL (H9N2 A/chicken/UDL-01/08) 31 (developed in collaboration with M. Iqbal, Pirbright Institute, UK) and Ty05 (H5N1 A/Turkey/Turkey/5/2005) (a kind gift from R. Fouchier, Erasmus University, Netherlands). The PB2(E627K) substitution was made to 50-92 and Ty05 (K627E) by overlapping PCR of the PB2 plasmid as previously described 11 . Ty05:PR8 6:2 recombinant virus was generated with the HA and NA derived from PR8 and the internal genes of Ty05; virus rescue was performed by co-transfection of the 12-plasmid system: 8 polI plasmids as described above and 4 helper expression plasmids encoding A/Victoria/3/75 (VIC) polymerase components and NP expressed by the pCAGGS vector, as previously described 32, 33 . UDL virus rescue was performed by co-transfection of a 9 plasmid system including: 7 bidirectional pHW2000 plasmids 34 encoding PB2, PA, HA, NA, NP, NS and M genes, together with a polI plasmid encoding PB1 and a pCAGGS expression plasmid of the UDL-PB1 gene. Ty05 virus stocks were propagated in 9-day-old embryonated chicken eggs incubated at 37 °C. UDL virus stocks were generated in MDCK cells with infection media (serum free DMEM supplemented with 1% penicillin-streptomycin and 1 μ g ml −1 TPCK-treated trypsin (Lorne Labs)) and incubated at 37 °C. Clinical isolate A/England/691/2010 (H3N2) (Public Health England) was propagated in MDCK cells with infection media. Aliquots of infectious virus were stored at − 80 °C. Infectious titres were determined by plaque assay on MDCK cells. Influenza A virus infection. 293T cells were transfected with ANP32A (500 ng, 24-well) using Lipofectamine 3000 (Invitrogen) and after 20 h infected with virus diluted in serum free DMEM for 1 h at 33 or 37 °C (MOI as indicated in the relevant figure legends) and replaced with cell culture medium (for qRT-PCR analysis) or DMEM supplemented with 0.1% FCS and 1 μ g ml −1 TPCK trypsin (Worthington-Biochemical) (for infectious virus titres). shRNA A549 cells were infected with virus as for 293T cells, except infection media lacked FCS. Infected cell lysates and cell supernatants were harvested at 12 and/or 24 h post-infection. Infectious titres were determined by plaque assay on MDCK cells. Safety/biosecurity. All work with infectious agents was conducted in biosafety level 2 facilities, approved by the Health and Safety Executive of the UK and in accordance with local rules, at Imperial College London, UK. Polymerase assay. Influenza polymerase activity was measured by use of a minigenome reporter which contains the firefly luciferase gene flanked by the non-coding regions of the influenza NS gene segment, transcribed from a species-specific polI plasmid with a mouse terminator sequence 35 . The human and chicken polI minigenomes (pHOM1-Firefly and pCOM1-Firefly) are described previously 36 ; pMouse-PolI-Firefly was generated by substituting in the mouse polI promoter sequence 37 . pCAGGS expression plasmids encoding each polymerase component and NP for 50-92 (H5N1 A/Turkey/England/50-92/91), Ty05, VIC and BAV (A/Duck/Bavaria/1/77) are described previously 11, 36, 38 . UDL PB1, PB2, PA and NP genes were sub-cloned into the pCAGGS plasmid. Mutagenesis of PB2 genes to encode PB2 627K or 627E was performed by overlapping PCR as described previously 11, 36 . All plasmid constructs were verified by DNA sequencing. Primers and sequence information are available upon request. To measure influenza polymerase activity, 293T cells were transfected in 48-well plates with pCAGGS plasmids encoding the PB1 (20 ng), PB2 (20 ng), PA (10 ng) and NP (40 ng) proteins, together with 20 ng species-specific minigenome reporter and 10 ng Renilla luciferase expression plasmid (pCAGGS-Renilla) 39 as an internal control, using Lipofectamine 3000 transfection reagent (Invitrogen) according to manufacturers' instructions. Wg3h, RH clones and DF-1 cells were transfected as 293T cells but with twice the concentration of DNA and using Lipofectamine 2000 (Invitrogen). Cells were incubated at 37 °C. 20 h after transfection, cells were lysed with 50 μ l of passive lysis buffer (Promega), and firefly and Renilla luciferase bioluminescence was measured using a Dual-luciferase system (Promega) with a FLUOstar Omega plate reader (BMG Labtech). The effect of cellular factors on influenza polymerase was examined by polymerase assay after expression of constructs (250 ng) for 24 h. shRNA mediated silencing. Silencing was achieved by lentivirus delivery of shRNA encoding transgenes. Lentiviral vectors were generated using the TRC1.5-pLKO.1-puro plasmid (MISSION Sigma-Aldrich) containing the shRNA sequence and puromycin selection gene. shRNA sequences for target genes were as follows: huANP32A (TRCN0000006905, 5′ -CC GG CC TG AA GA TG AG GG AG A A GA TC TC GA GA TC TT CT CC CTCATCTTCAGGTTTTT-3′ (target sequence, 5′ -CCTGAAGATGAGGGAGAAGAT-3′ )), huANP32B (TRCN0000077928, 5 ′ -CC GG CC AC CC AA AG AG CC AA AG AA TC TC GA GA TT CT TT GG CTCTTTG GGTGGTTTTTG-3′ (target sequence, 5′ -CCACCCAAAGAGCCAAAGAAT-3′ )), chANP32A (TRCN0000006902, 5′ -CCGGCCTATTGTGATTTGACTGTT TCTCGAGAAACAGTCAAATCACAATAGGTTTTT-3′ (target sequence, 5′ -CCTATTGTGATTTGACTGTTT-3′ )) and Negative (SHC002, Non-Mammalian shRNA Control) (MISSION Sigma-Aldrich). Lentiviruses were generated by co-transfection in 293T cells with pCMV-delta8.2 40 , pCAGG-VSV G 41 and TRC1.5-pLKO.1-puro at a ratio of 1:0.25:1 using Lipofectamine 3000 (Invitrogen), cell culture media was replaced after 16hrs at a reduced volume and supernatant MethOds Cells and cell culture. Chinese Hamster cell line (Wg3h), chicken genome RH clones (Laboratoire de génétique cellulaire, Institut National de la Recherche Agronomique, Castanet-Tolosan, France) 17 , human embryonic kidney (293T) (ATCC), human lung adenocarcinoma epithelial cells (A549) (ATCC) and Madin-Darby canine kidney (MDCK) cells (ATCC) were maintained in cell culture media (Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 10% fetal calf serum (FCS) (Biosera) and with 1% penicillin-streptomycin (Invitrogen)). Chicken fibroblast (DF-1) (ATCC) cells were maintained in DF-1 cell culture media (DMEM supplemented with 10% FCS, 5% tryptose phosphate broth (Sigma-Aldrich) and 0.1% penicillin-streptomycin (Invitrogen)). Cell lines were maintained at 37 °C in a 5% CO 2 atmosphere. Cell lines were authenticated by RT-PCR and verified negative for mycoplasma. Microarray analysis. Total RNA was extracted from 1 × 10 6 cells that were of the same passage as those tested for polymerase, using an RNeasy kit (Qiagen) according to the manufacturer's instructions. On-column DNA digestion was performed using RNase-free DNase (Qiagen) to remove contaminating genomic DNA. RNA samples were quantified using a Nanodrop Spectrophotometer (Thermo Scientific) and checked for quality using a 2100 Bioanalyzer (Agilent Technologies). All RNA samples had an RNA integrity number (RIN) ≥ 9.8. Array hybridization was performed according to the manufacturer's instructions (Affymetrix). Labelled samples were hybridized to the Affymetrix Chicken Gene 1.0 ST Arrays in a GeneChip Hybridization Oven for 16 h at 45 °C and 60 rpm in an Affymetrix Hybridization Oven 645. After washing and staining, the arrays were scanned with the Affymetrix GeneChip Scanner 3000 7G. Gene-level expression signal estimates were derived from CEL files generated from raw data using the multi-array analysis (RMA) algorithm implemented from the Affymetrix GeneChip Command Console Software Version 3.0.1. Data Pre-Processing and filtering was done using Partek Software Version 6.6 and included: RMA background correction, quantile normalization across all chips in the experiment, log 2 transformation and median polish summarization. Statistically significant genes were discovered by comparisons between the positive RH clones, parent cells and negative RH clones by two-way ANOVA (variables: clone and passage number) adjusted with the Benjamini-Hochberg multiple-testing correction (false discovery rate (FDR) of P < 0.05). Statistically significant genes were identified and those with fold-change values < | ± 1.5| were removed. Cloning of candidate cDNAs. Sequence specific primers were used to amplify targeted cellular transcripts of chicken genes from chromosome 10, including: ANP32A, RAB11A (Ras-related protein Rab-11A), TIPIN (TIMELESS Interacting Protein), RPL4 (Ribosomal Protein L4), PIAS1 (Protein Inhibitor Of Activated STAT, 1), TLE3 (Transducin-Like Enhancer Of Split 3), EIF3J (Eukaryotic Translation Initiation Factor 3, Subunit J) and CTDSPL2 (CTD (Carboxy-Terminal Domain, RNA Polymerase II, Polypeptide A) Small Phosphatase Like 2) from total RNA extracted from RH clone 476, using SuperScript III One-Step RT-PCR System (Invitrogen). Chicken ANP32B, DDX17 (DEAD (Asp-Glu-Ala-Asp) Box Helicase 17), IMPα 1, 3 and 7 (Importin α -1,3 and 7) cDNAs were amplified from RNA extracted from DF-1 cells. PCR products were cloned into the pCAGGS expression vector. cDNAs of full length ANP32A isoforms of several species were generated by gene synthesis (GeneArt Strings DNA Fragments) and inserted into the pCAGGS expression vector, based on the following sequences: Chicken ANP32A (chANP32A) (Gallus gallus, XP_413932.3), human ANP32A (huANP32A) (Homo sapiens, NP_006296.1), zebra finch ANP32A (zfANP32A) (Taeniopygia guttata, XP_012424064.1), duck ANP32A (dkANP32A) (Anas platyrhynchos, XP_005023024.1), turkey ANP32A (tyANP32A) (Meleagris gallopavo, XP_010715918.1), ostrich ANP32A (osANP32A) (Struthio camelus australis, XP_009665579.1), pig ANP32A (pgANP32A) (Sus scrofa, XP_003121807.3), mouse ANP32A (muANP32A) (Mus musculus, NP_033802.2), chicken ANP32B (chANP32B) (Gallus gallus, NP_001026105.1) and human ANP32B (huANP32B) (Homo sapiens, NP_006392.1). The sequence of dkANP32A was amended to contain the sequence encoding the intact N terminus by comparison with duck RNA-seq data (from ENA_ERP005909) that had been de novo assembled (using CLC Genomic Workbench 7.5.1), where the appropriate contig was identified by BLASTX against the chicken ANP32A protein sequence. Furthermore, the duck sequence was confirmed by reverse-transcription of ANP32A mRNA derived from duck embryonic fibroblast cells and DNA sequencing. Mutants of these sequences were also generated by gene synthesis, as above, and included: chANP32A Δ 33 (chANP32A with the 'avian insertion' deleted (aa176-208)), huANP32A+ 33 and huANP32B+ 33 (huANP32A and B with the avian sequence -VLSLVKDRDDKEAPDSDAEGYVEGLDDEEEDED-inserted after aa175 (huANP32A) and aa173 (huANP32B)). All plasmid constructs were verified by DNA sequencing. Primers and sequence information are available upon request. Generation of recombinant and clinical Influenza A virus. Reverse genetics systems for the following virus strains were used in this study: PR8 (H1N1 A/Puerto Letter reSeArCH harvested at 36 h post-transfection before being filtered (0.45 μ m) and aliquots frozen at − 80 °C. 293T, A549 or DF-1 cells were transduced with lentiviral vectors for 16 h before media was replaced. After 72 h incubation, cells were split and cell culture media was replaced containing 0.5 μ g ml −1 puromycin (Invivogen). Cells were incubated a further 72 h after selection before analysis. siRNA mediated silencing. DF-1, 293T or RH clone 476 cells were transfected with 100 nM of siRNA using HiPerFect transfection reagent in 48-well plates, according to manufacturer's instructions (Qiagen). 48 h later cells were transfected with polymerase and minigenome constructs and harvested after a further 20 h, for luciferase quantification and knockdown analysis. Total RNA was extracted as described previously but with 100 μ l of cell lysate added to AVL buffer before continuing with the RNeasy mini kit (Qiagen). siRNAs for target genes were as follows:, AllStars Negative Control, huANP32A (SI02655212 FlexiTube), huANP32B (SI02655380 FlexiTube) (Qiagen), 50-92 NP (5′ -AAGGAUCUUAUUUCUUCGGAG-3′ ), chANP32A (5′ -GAGCTGGAATTCTTGAGTACA-3′ ) (custom RNA oligos, Sigma-Aldrich). Quantification of chANP32A and B mRNA levels. Total RNA from RH clones and DF-1 cells were extracted using an RNeasy mini kit (Qiagen), following manufacturer's instructions. During extraction of RNA, RNeasy columns were treated with RNase-Free DNase (Qiagen). RNA samples were quantified using a Nanodrop Spectrophotometer (Thermo Scientific). Equal concentrations of RNA were subject to first strand synthesis using QuantiTect Reverse Transcription Kit (Qiagen) with primers specific for chANP32A (5′ -CAACTGTAGGTCATACGAAGGC-3′ ) and chANP32B (5′ -GGTGGCCTTGAAGTTCTAGC-3′ ). This product was then quantified with Mesa Green quantitative PCR (qPCR) MasterMix Plus for SYBR Assay I dTTP (Eurogentec) using the primers for first strand synthesis together with chANP32A (5′ -GTTTGCAACTGAGGCTAAGC-3′ ) and chANP32B (5′ -ATGAGCATCGTCACCTCGC-3′ ). Real-time quantitative PCR analysis was performed (Applied Biosystems ViiA 7 Real-Time PCR System) and absolute copy numbers of either chANP32A or B calculated using a standard curve of known concentrations of the corresponding cDNA expression plasmid. Primers were designed to be specific to their target transcripts by using BLASTX against both the hamster and chicken genomes. Quantification of RNA generated by influenza polymerase. Purified total RNA (1000 ng) was subject to first-strand cDNA synthesis with gene specific primers, oligo(dT)20 or random hexamers (to amplify mRNA) using SuperScript III (Invitrogen) followed by RNase H treatment (Invitrogen). Primer design was based on Obayashi et al. (2008) 42 for quantification of RNA species of the luciferase minigenome driven by reconstituted polymerase, and UDL PB2 RNA species were quantified using a tagged-primer system adapted from Kawakami et al. (2011) 43 . First strand primers included: luciferase vRNA (5′ -TATGAACATTTCGCAGCCTACCGTAGTGTT-3′ ), luciferase cRNA (5′ -AGTAGAAACAAGGGTG-3′ ), luciferase mRNA (Oligo(dT)20), UDL PB2 vRNA (5′ -GGCCGTCATGGTGGCGAAT (tag) GATGCGTGATGTATT GGGAAC-3′ ), UDL PB2 cRNA (5′ -GCTAGCTTCAGCTAGGCATC (tag) AGTAGAA ACAAGGTCGTT-3′ ), UDL PB2 mRNA (Oligo(dT)20) and 18S ribosomal RNA (Random Hexamers (Invitrogen)). After first strand synthesis, 1 μ l of cDNA was subject to real-time quantitative PCR analysis with a gene specific primer pair using SYBR green PCR mix (Applied Biosystems) and analysed on the Applied Biosystems ViiA 7 Real-Time PCR System. Gene specific primer pairs were as follows: Luciferase gene (5′ -CCGGAATGATTTGATTGCCA-3′ and 5′ -TATGAACATTTCGCAGCCTACCGTAGTGTT-3′ ), UDL PB2 vRNA (5′ -GGCCGTCATGGTGGCGAAT (tag) -3′ and 5′ -CCTCTCAACACTGCA GATTCC-3′ ), UDL PB2 cRNA (5′ -GCTAGCTTCAGCTAGGCATC (tag) -3′ and 5′ -GGAATCTGCAGTGTTGAGAGG-3′ ), UDL PB2 mRNA (5′ -GATGCGT GATGTATTGGGAAC-3′ and 5′ -CCTCTCAACACTGCAGATTCC-3′ ) and 18S ribosomal RNA (5′ -GCAAATTACCCACTCCCG-3′ and 5′ -CTGCAGCAA CTTTAATATACGC-3′ ). Fold change RNA to PB2 627E with Empty vector was calculated by Δ Δ C T including normalization to C T values of 18S ribosomal RNA. Immunoblot analysis. Cells were lysed in Passive Lysis buffer (Promega) or NP40 lysis buffer (for cellular fractionation) and prepared in Laemmli 2× buffer (Sigma-Aldrich). Cell proteins were resolved by SDS-PAGE using Mini-PROTEAN TGX Precast Gels (Bio-Rad). Immunoblotting was carried out using the following primary antibodies: anti-chANP32A rabbit polyclonal (LS-B10851, LifeSpan BioSciences, Inc.), anti-huANP32A rabbit polyclonal (AB51013, Abcam), anti-huANP32B rabbit monoclonal (AB184565, Abcam), α-vinculin rabbit monoclonal (AB129002, Abcam), anti-Flag M2 mouse monoclonal (F1804 or F3165, Sigma-Aldrich), anti-PB2 rabbit polyclonal (2N580, a kind gift from Paul Digard, Roslin Institute), and followed with secondary horseradish peroxidase-conjugated (HRP) antibodies: anti-mouse IgG (H/L):HRP goat polyclonal (STAR117P, AbD Serotec) and anti-rabbit IgG:HRP sheep polyclonal (STAR54, AbD Serotec). For quantification of cellular fractions, the following secondary antibodies were used: anti-rabbit IgG (H/L):DyLight 800 (5151P, Cell signalling) and anti-mouse IgG (H/L):DyLight 680 (5470P, Cell signalling). Protein bands were visualized by chemiluminescence (ECL+ western blotting substrate, Pierce) using a FUSION-FX imaging system (Vilber Lourmat). Cellular Fractionation. 293T cells were transfected with empty vector or ANP32 plasmid together with the polymerase complex and NP of 50-92 (PB2 627E) and pHOM1-firefly minigenome reporter. After 24 h, cells monolayers were washed in ice-cold PBS and lysed in 0.1% NP40 buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.1% NP40 and protease inhibitors (EDTA-free COMPLETE tablet (Roche)). Total lysates were centrifuged at 228 g for 5 min at 4 °C. Supernatant was removed (Cytoplasmic fraction) and the nuclear pellet was resuspended in 1% NP40 (as above) and subject to syringing with a 25G needle. Fractions were analysed by immunoblotting. Bioinformatic and statistical analysis. Analysis of Microarray data was performed as previously mentioned, using Affymetrix GeneChip Command Console Software Version 3.0.1. and Partek Software Version 6.6. Statistical analysis of biological replicates was performed by One-way ANOVA with Dunnett's multiple comparison analysis or Two-way ANOVA with Šidák multiple comparison analysis, using GraphPad Prism 6. Sequence alignments were performed using Geneious R6 software. Quantification of immunoblots was performed using Image Studio Lite V5.2.
No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. Letter reSeArCH extended data table 1 | Genes common between the avian influenza polymerase positive radiation hybrid cells Chromosome  Venn 1  IQSEC3  1  CCDC77  1  WNK1  1  KDM5A  1  MAP2K1  10  ZWILCH  10  PIAS1  10  FEM1B  10  GLCE  10  KIF23  10  SPG11  10  TIPIN  10 Microarray analysis of RNA extracted from RH clones revealed the expression of chicken genes. The gene list from Venn 1 shows common genes between the P1 positive hybrid clones when compared to parent Wg3h hamster cells. The gene list from Venn 2 shows common genes between P12 positive hybrid clones when compared to parent and 365P1 (positive RH clone) vs 365P12 (reverted RH clone). This analysis accompanies the microarray analysis Venn diagrams in Fig. 1b and c.
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